Staphylococcus aureus is one of the most important strains, from a clinical point of view. Indeed, in specific conditions, such as weakness of the immune system of the host, this bacterium can lead to severe pathologies. Therefore, antistaphylococcal agents able to acts on resistant germs are an urgent unmet medical need. The S. aureus protein RnpA has been recently recognized as a potential target for the development of antimicrobials, since it is involved in two crucial processes of the bacterium: mRNA degradation and tRNA maturation. In the present work, for the first time in literature a computational model is reported. A Hotspots Maps calculation has been performed, to define one main area as the potential binding site. Then, RNPA2000 and JC1/2, known RnpA inhibitors, were docked allowing us to identify the key interactions between these inhibitors and RnpA. After this validation, an in-depth SAR analysis of RnpA inhibitors was achieved, designing and computationally evaluating a series of novel derivatives. For the obtainment of this novel set of compounds, peculiar synthetic pathways were designed and refined. After their purification and characterization, all the compounds underwent both in vitro and cellular assays, to evaluate their capability to interact and to inhibit RnpA, as well as their antimicrobial activity. Several compounds showed promising activity, in terms of MIC and inhibitory activity vs RnpA. This work opens up for further computational-guided drug design of RnpA inhibitors, aiming at obtaining potent inhibitors.

RnpA inhibitors as potential antistaphylococcal agents: computational design, synthesis, and biological evaluation / L. Suigo, M. Chojnacki, C. Zanotto, V. Sebastián-Pérez, G. Lodigiani, P. Dunman, E. Valoti, V. Straniero. ((Intervento presentato al convegno MYCS Merck Young Chemists' Symposium : Novamber, 21st - 23rd tenutosi a Rimini nel 2022.

RnpA inhibitors as potential antistaphylococcal agents: computational design, synthesis, and biological evaluation

L. Suigo
Primo
;
C. Zanotto;G. Lodigiani;E. Valoti
Penultimo
;
V. Straniero
Ultimo
2022

Abstract

Staphylococcus aureus is one of the most important strains, from a clinical point of view. Indeed, in specific conditions, such as weakness of the immune system of the host, this bacterium can lead to severe pathologies. Therefore, antistaphylococcal agents able to acts on resistant germs are an urgent unmet medical need. The S. aureus protein RnpA has been recently recognized as a potential target for the development of antimicrobials, since it is involved in two crucial processes of the bacterium: mRNA degradation and tRNA maturation. In the present work, for the first time in literature a computational model is reported. A Hotspots Maps calculation has been performed, to define one main area as the potential binding site. Then, RNPA2000 and JC1/2, known RnpA inhibitors, were docked allowing us to identify the key interactions between these inhibitors and RnpA. After this validation, an in-depth SAR analysis of RnpA inhibitors was achieved, designing and computationally evaluating a series of novel derivatives. For the obtainment of this novel set of compounds, peculiar synthetic pathways were designed and refined. After their purification and characterization, all the compounds underwent both in vitro and cellular assays, to evaluate their capability to interact and to inhibit RnpA, as well as their antimicrobial activity. Several compounds showed promising activity, in terms of MIC and inhibitory activity vs RnpA. This work opens up for further computational-guided drug design of RnpA inhibitors, aiming at obtaining potent inhibitors.
Settore CHIM/08 - Chimica Farmaceutica
Società Chimica Italiana (SCI)
https://www.soc.chim.it/sci_giovani/eventi/congressi/mycs2022
RnpA inhibitors as potential antistaphylococcal agents: computational design, synthesis, and biological evaluation / L. Suigo, M. Chojnacki, C. Zanotto, V. Sebastián-Pérez, G. Lodigiani, P. Dunman, E. Valoti, V. Straniero. ((Intervento presentato al convegno MYCS Merck Young Chemists' Symposium : Novamber, 21st - 23rd tenutosi a Rimini nel 2022.
Conference Object
File in questo prodotto:
File Dimensione Formato  
Poster_MYCS2022_LorenzoSuigo.pptx

accesso aperto

Tipologia: Altro
Dimensione 929.18 kB
Formato Microsoft Powerpoint XML
929.18 kB Microsoft Powerpoint XML Visualizza/Apri
Poster_MYCS2022_LorenzoSuigo.pdf

accesso aperto

Tipologia: Altro
Dimensione 667.28 kB
Formato Adobe PDF
667.28 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/951578
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact